Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Plazomicin on Metformin PK in Healthy Subjects
NCT03270553Phase 1Completed
- Sponsor
- Achaogen, Inc.
- Start
- Aug 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of plazomicin in complicated urinary tract infection (cUTI) and pyelonephritis (2 arms), sponsored by Achaogen, Inc. Primary endpoint: Pharmacokinetics of metformin in plasma at 9 days. Started Aug 2017; status: completed.
02
Drugs
plazomicin
03
Conditions
complicated urinary tract infection (cUTI)pyelonephritis
Beyond the preview
Go deeper on NCT03270553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03270553.